Search results 1-2 of 2 in Pancreatic cystic neoplasms
Results
-
Rochester, Minn.
View Summary
Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms
Location:
Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
Subjects will undergo EUS and/or ERCP as outpatients. For cysts shown to communicate with the main pancreas duct, a balloon catheter will be placed in the main pancreatic duct via ERCP. The balloon catheter will isolate the cyst from the main pancreatic duct, allowing ethanol injections of the cyst. A pancreatic duct stent will be placed in some patients, requiring repeat endoscopy for removal at another time.
NCT ID:
NCT01057355
Who can I contact for additional information about this study?
Rochester: Magdalen Clemens 507-538-2555
Mark Topazian, MD 507-266-6931
-
Phoenix/Scottsdale, Ariz., Jacksonville, Fla.
View Summary
A Multicenter, Prospective, Randomized Study on Endosonographic Evaluation of Pancreatic Cystic Lesions Using 22 G, 19 G, and Flexible 19 G Fine Needle Aspiration
Location:
Phoenix/Scottsdale, Ariz., Jacksonville, Fla.
Trial status:
Open for Enrollment
Why is this study being done?
To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) drainage, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of mucinous (pre-malignant) and non-mucinous cysts.
NCT ID:
NCT01711294
Who can I contact for additional information about this study?
Scottsdale: Douglas Faigel, MD 480-301-8000
Jacksonville: Michael B Wallace, MD 904-953-7382